Androgen deprivation therapy as backbone therapy in the management of prostate cancer

od Merseburger, Axel S, Alcaraz, Antonio, von Klot, Christoph A
Wydane w Onco Targets Ther (2016)

An update on enzalutamide in the treatment of prostate cancer

od Merseburger, Axel S., Haas, Gabriel P., von Klot, Christoph-A.
Wydane w Ther Adv Urol (2015)

Novel therapeutic options for second-line therapy in metastatic renal cell carcinoma

od VON KLOT, CHRISTOPH-A. J., MERSEBURGER, AXEL S., KUCZYK, MARKUS A.
Wydane w Mol Clin Oncol (2016)

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

od Vassis, Stratos, Nöldeke, Beatrice, Christiansen, Hans, von Klot, Christoph A., Merten, Roland
Wydane w Strahlenther Onkol (2020)

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy

od Henkenberens, Christoph, Oehus, Ann-Kathrin, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Janssen, Stefan, Christiansen, Hans, von Klot, Christoph A. J.
Wydane w Strahlenther Onkol (2020)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

od Katzendorn, Olga, Peters, Inga, Dubrowinskaja, Natalia, Tezval, Hossein, Tabrizi, Pouriya Faraj, von Klot, Christoph A., Hennenlotter, Jörg, Lafos, Marcel, Kuczyk, Markus A., Serth, Jürgen
Wydane w BMC Cancer (2021)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy

od von Klot, Christoph A., Kuczyk, Markus A., Boeker, Alena, Reuter, Christoph, Imkamp, Florian, Herrmann, Thomas R.W., Tezval, Hossein, Kramer, Mario W., Perner, Sven, Merseburger, Axel S.
Wydane w Oncol Lett (2017)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma

od von Klot, Christoph-A, Kramer, Mario W, Peters, Inga, Hennenlotter, Joerg, Abbas, Mahmoud, Scherer, Ralph, Herrmann, Thomas RW, Stenzl, Arnulf, Kuczyk, Markus A, Serth, Juergen, Merseburger, Axel S
Wydane 2014

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer

od Henkenberens, Christoph, Derlin, Thorsten, Bengel, Frank, Ross, Tobias L., Kuczyk, Markus A., Giordano, Frank A., Sarria, Gustavo R., Schmeel, Leonard Christopher, Christiansen, Hans, von Klot, Christoph A. J.
Wydane w Front Oncol (2021)

Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer

od Hupe, Marie C., Dormayer, Lukas, Ozimek, Tomasz, Struck, Julian P., Hennig, Martin J. P., Klee, Melanie, von Klot, Christoph A. J., Kuczyk, Markus A., Merseburger, Axel S., Kramer, Mario W.
Wydane w BMC Cancer (2020)

Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature

od Fuhrmann, Christian, Struck, Julian P., Ivanyi, Philipp, Kramer, Mario W., Hupe, Marie C., Hensen, Bennet, Fürschke, Alexander, Peters, Inga, Merseburger, Axel S., Kuczyk, Markus A., von Klot, Christoph-A. J.
Wydane w Front Oncol (2020)

Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario

od Struck, Julian P., Kramer, Mario W., Katzendorn, Olga, Hupe, Marie C., Ozimek, Tomasz, Hennig, Martin J. P., Wießmeyer, Judith R., von Klot, Christoph A. J., Kuczyk, Markus A., Kreipe, Hans H., Merseburger, Axel S., Perner, Sven, Dressler, Franz F.
Wydane w Adv Ther (2020)